Cargando…
An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
Nucleic acid (NA)-based biopharmaceuticals have emerged as promising therapeutic modalities. NA therapeutics are a diverse class of RNA and DNA and include antisense oligonucleotides, siRNA, miRNA, mRNA, small activating RNA, and gene therapies. Meanwhile, NA therapeutics have posed significant stab...
Autores principales: | Ingle, Rahul G., Fang, Wei-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143938/ https://www.ncbi.nlm.nih.gov/pubmed/37111643 http://dx.doi.org/10.3390/pharmaceutics15041158 |
Ejemplares similares
-
Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges
por: Oshchepkova, Anastasiya, et al.
Publicado: (2023) -
ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery
por: Hueso, Miguel, et al.
Publicado: (2021) -
Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery
por: Boisguérin, Prisca, et al.
Publicado: (2021) -
Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
por: Du, Rong, et al.
Publicado: (2022) -
Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics
por: Khar, R. K., et al.
Publicado: (2010)